Gilead Sciences records robust growth with $8.3 billion in Q3 revenue
GILD Gilead Sciences Inc
$169.73 -0.67%
View chart & analysis → - 1Gilead Sciences reported Q3 revenue of $8.3 billion, a 7% increase from the previous year.
- 2Gilead Sciences recorded non-GAAP earnings per share of $2.55 in the third quarter.
- 3Gilead Sciences shares rose 39% this year, outperforming the S&P 500 index rise of 11%.
So what's the key point?
Gilead Sciences' third-quarter revenue grew by 7% compared to last year. The stock price has risen much more than the market average this year.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.